Renalytix AI plc (RENX) - Total Liabilities
Based on the latest financial reports, Renalytix AI plc (RENX) has total liabilities worth GBX12.81 Million GBX (≈ $1.56K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Renalytix AI plc - Total Liabilities Trend (2012–2025)
This chart illustrates how Renalytix AI plc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Renalytix AI plc to evaluate short-term liquidity relative to the company's equity base.
Renalytix AI plc Competitors by Total Liabilities
The table below lists competitors of Renalytix AI plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LPA Group
LSE:LPA
|
UK | GBX9.78 Million |
|
Petros Pharmaceuticals Inc
NASDAQ:PTPI
|
USA | $27.19 Million |
|
OCA Acquisition Corp
NASDAQ:OCAXU
|
USA | $15.99 Million |
|
INSURAGUEST TECHN. INC.
F:4JG
|
Germany | €703.54K |
|
Wishbone Gold Plc
LSE:WSBN
|
UK | GBX155.25K |
|
Marechale Capital Plc
LSE:MAC
|
UK | GBX123.20K |
Liability Composition Analysis (2012–2025)
This chart breaks down Renalytix AI plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RENX stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -9.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Renalytix AI plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Renalytix AI plc (2012–2025)
The table below shows the annual total liabilities of Renalytix AI plc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX13.10 Million ≈ $1.59K |
-17.22% |
| 2024-06-30 | GBX15.83 Million ≈ $1.93K |
-99.97% |
| 2023-12-31 | GBX54.50 Billion ≈ $6.63 Million |
+230225.83% |
| 2023-06-30 | GBX23.66 Million ≈ $2.88K |
+17.79% |
| 2022-06-30 | GBX20.09 Million ≈ $2.44K |
+168.71% |
| 2021-06-30 | GBX7.48 Million ≈ $909.61 |
+40.10% |
| 2020-06-30 | GBX5.34 Million ≈ $649.24 |
+606.75% |
| 2019-06-30 | GBX755.00K ≈ $91.86 |
+1043.68% |
| 2018-06-30 | GBX66.02K ≈ $8.03 |
-100.00% |
| 2016-12-31 | GBX41.52 Billion ≈ $5.05 Million |
+5.56% |
| 2015-12-31 | GBX39.33 Billion ≈ $4.79 Million |
-3.76% |
| 2014-12-31 | GBX40.87 Billion ≈ $4.97 Million |
-3.33% |
| 2013-12-31 | GBX42.28 Billion ≈ $5.14 Million |
+6.03% |
| 2012-12-31 | GBX39.87 Billion ≈ $4.85 Million |
-- |
About Renalytix AI plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from … Read more